eMedicine Specialties > Sports Medicine > Knee

Anterior Cruciate Ligament Injury: Treatment & Medication

Author: John D Hubbell, MD, Consulting Surgeon, Department of Orthopedic Surgery, Southampton Hospital
Coauthor(s): Evan Schwartz, MD, Director of Orthopedic Surgery, St John's Queens Hospital, New York Medical College; Assistant Professor, Department of Surgery, Albert Einstein School of Medicine
Contributor Information and Disclosures

Updated: Mar 7, 2006

Treatment

Acute Phase

Rehabilitation Program

Physical Therapy

Before any treatment, encourage strengthening of the quadriceps and hamstrings, as well as ROM exercises. Performance of ROM helps reduce the amount of effusion and regain motion and strength.

Surgical Intervention

When deciding whether to perform reconstructive surgery, the physician should consider the following factors:

  • Preinjury activity level
  • Desire to return to high-demand sports (eg, basketball, football, soccer)
  • Associated injuries
  • Abnormal laxity
  • Patient's expectations

Generally, the recommendation is that surgical intervention be delayed at least 3 weeks following injury to prevent the complication of arthrofibrosis. The methods of surgical repair may be categorized into 3 groups, primary repair, extra-articular repair, and intra-articular repair.

  • Primary repair is not recommended except for bony avulsions, which are mostly seen in adolescents. Because the ACL is intra-articular, the ligamentous ends are subjected to synovial fluid, which does not support ligamentous healing.
  • Extra-articular repair generally involves a tenodesis of the iliotibial tract. This may prevent a pivot shift but has not been shown to decrease anterior tibial translation.
  • Intra-articular reconstruction of the ACL has become the criterion standard for treating ACL tears.

    • Bone-patella-bone autografts are currently popular because they yield a significantly higher percentage of stable knees with a higher rate of return to preinjury sports. The major pitfall of these grafts is their association with postoperative anterior knee pain (10-40%).
    • Hamstring tendon grafts are associated with a faster recovery and less anterior knee pain. Critics believe that these are more susceptible to graft elongation.
    • Recent literature has supported a greater tensile strength with the use of braided quadruple hamstring grafts. However, this finding has not been confirmed in vivo, and the graft may be limited by the type of fixation.
    • Allografts have also been very popular because of their efficiency, their ability to provide bony fixation, and the lack of associated patella morbidity. However, they are associated with a risk of viral transmission. Allografts are best used in revisions. These have also fallen out of favor by some because several deaths linked to clostridial infections from inadequate sterilization techniques have been reported, which led to increased research into sterilization techniques to ensure safety. In addition, concerns exist regarding what effects the immunologic response and delayed revascularization and remodeling may have on clinical outcomes. Although allografts are generally accepted as having less associated morbidity, no proof of this is present in the literature.
    • Synthetic grafts and ligament augmentation devices have also been used. Synthetic grafts are no longer acceptable, because of their high rate of complications, including failure and aseptic effusions.
    • Intra-articular reconstruction may be performed through a 2-incision technique or a single-incision endoscopic technique; the latter is currently more popular. This procedure requires graft stabilization with some type of fixation hardware for all of the graft options. The stabilization may be performed with metal interference screws, bioabsorbable screws, endobuttons, and cross pins. Each device has its own benefits.
    • Double-tunnel ACL reconstructions attempt to reproduce stability in internal rotation and valgus torque applied to the knee. Investigations into the benefits of such surgical treatment versus the increased level of difficulty and operative time are currently ongoing. Studies at this time have been limited to animal models.

Other Treatment

Nonoperative treatment may be considered in elderly patients or in less active athletes who may not be participating in any pivoting type of sports (eg, running, cycling). The goal is to obtain a full ROM and strength compared with the uninjured knee. This modality of treatment requires modification of activity levels and avoidance of physically demanding occupations. Arthroscopy may also be considered for persons who are poor candidates for reconstruction but have a mechanical block to ROM. The goal of this procedure is to debride the remaining stump to increase motion. Patients with significant arthritis are also thought to be poor candidates unless they are experiencing recurrent instability. See below for bracing information.

Recovery Phase

Rehabilitation Program

Physical Therapy

Postoperative treatment is discussed.

  • Closed-chain exercises are used to emphasize early and long-term maintenance of full extension.
  • Therapy protocols may be divided into the following 4 categories per Shelbourne and Nitz:

    • Phase I: This is the preoperative period when the goal is to maintain full ROM.
    • Phase II (0-2 wk): The goal is to achieve full extension, maintain quadriceps control, minimize swelling, and achieve flexion to 90o.
    • Phase III (3-5 wk): Maintain full extension and increase flexion up to full ROM. Stair-climbers and bicycles may be used.
    • Phase IV (6 wk): Increase strength and agility, progressive return to sports. Return to all sports without activity may take 6-9 months and should be closely monitored by the surgeon and physical therapist.

Other Treatment (Injection, manipulation, etc.)

The use of knee braces remains a highly controversial topic; braces are well accepted by patients, but most biomechanical studies do not support their use. Studies have shown that functional bracing can limit anterior translation of the tibia at low loads. Furthermore, most braces have been found to decrease the reaction time of the hamstring muscles.

Maintenance Phase

Rehabilitation Program

Physical Therapy

Open-chain exercises are initiated. The patient's timeframe for returning to sports depends on his/her strength, ROM, and the type of fixation that was performed.

Medication

Medication for ACL injuries mainly consists of analgesics. Preoperative drugs may include cyclooxygenase-2 (COX-2) inhibitors and opioid analgesic agents. Postoperatively, the patient may obtain pain relief through nonsteroidal anti-inflammatory drugs (NSAIDs) and opioid analgesics. NSAIDS have been shown to decrease bone formation in spine fusions and rotator cuff surgery. Although this has not been seen clinically in ACL reconstructions with bone-patella tendon-bone grafts, it is plausible to think that this may be the case. Therefore, long-term postoperative use may not be beneficial.

Nonsteroidal anti-inflammatory drugs

Have analgesic and anti-inflammatory activities. Their mechanism of action is not known, but may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation and various cell membrane functions.


Ketorolac (Toradol)

Inhibits prostaglandin synthesis by decreasing the activity of the enzyme, cyclo-oxygenase, which results in decreased formation of prostaglandin precursors. Used in postoperative pain control.

Adult

10 mg PO q6h for 5 d (requires IM/IV loading dose)
Alternatively, 15-30 mg IM/IV q6h for 5 d

Pediatric

Not established

Coadministration with aspirin increases risk of inducing serious NSAID-related adverse effects; probenecid may increase concentrations and, possibly, toxicity of NSAIDs; may decrease effect of hydralazine, captopril, and beta-blockers; may decrease diuretic effects of furosemide and thiazides; monitor PT closely (instruct patients to watch for signs of bleeding); may increase risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently

Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency; high risk of bleeding; do not administer into CNS

Pregnancy

C - Safety for use during pregnancy has not been established.

Precautions

Category D in third trimester of pregnancy; acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low WBC counts (rare) usually return to normal during ongoing therapy; discontinue therapy if persistent leukopenia, granulocytopenia, or thrombocytopenia occur

Cyclooxygenase-2 inhibitors

Although increased cost can be a negative factor, the incidence of costly and potentially fatal GI bleeds is clearly less with COX-2 inhibitors than with traditional NSAIDs. Ongoing analysis of cost avoidance of GI bleeds will further define the populations that will find COX-2 inhibitors the most beneficial.


Celecoxib (Celebrex)

Inhibits primarily COX-2. COX-2 is considered an inducible isoenzyme, induced during pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited thus GI toxicity may be decreased. Seek lowest dose of celecoxib for each patient. Used for postoperative pain control.

Adult

100 mg PO bid or 200 mg PO qd

Pediatric

Not established

Coadministration with fluconazole may cause increase in celecoxib plasma concentrations because of inhibition of celecoxib metabolism; coadministration of celecoxib with rifampin may decrease celecoxib plasma concentrations

Documented hypersensitivity to drug or sulfa

Pregnancy

C - Safety for use during pregnancy has not been established.

Precautions

May cause fluid retention and peripheral edema; caution in compromised cardiac function, hypertension, conditions predisposing to fluid retention; severe heart failure and hyponatremia, because may deteriorate circulatory hemodynamics; NSAIDs may mask usual signs of infection; caution in the presence of existing controlled infections; evaluate symptoms and signs suggesting liver dysfunction, or in abnormal liver lab results

More on Anterior Cruciate Ligament Injury

Overview: Anterior Cruciate Ligament Injury
Differential Diagnoses & Workup: Anterior Cruciate Ligament Injury
Treatment & Medication: Anterior Cruciate Ligament Injury
Follow-up: Anterior Cruciate Ligament Injury
Multimedia: Anterior Cruciate Ligament Injury
References

References

  1. Belanger MJ, Moore DC, Crisco JJ 3rd, Fadale PD, Hulstyn MJ, Ehrlich MG. Knee laxity does not vary with the menstrual cycle, before or after exercise. Am J Sports Med. Jul-Aug 2004;32(5):1150-7. [Medline].

  2. Beynnon BD, Johnson RJ, Abate JA, Fleming BC, Nichols CE. Treatment of anterior cruciate ligament injuries, part I. Am J Sports Med. Oct 2005;33(10):1579-602. [Medline].

  3. Cosgarea AJ, Sebastianelli WJ, DeHaven KE. Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft. Am J Sports Med. Jan-Feb 1995;23(1):87-92. [Medline].

  4. Daniel DM, Malcom LL, Losse G, Stone ML, Sachs R, Burks R. Instrumented measurement of anterior laxity of the knee. J Bone Joint Surg Am. Jun 1985;67(5):720-6. [Medline].

  5. Gardner E, O'Rahilly R. The early development of the knee joint in staged human embryos. J Anat. Jan 1968;102(2):289-99. [Medline].

  6. Getelman MH, Friedman MJ. Revision anterior cruciate ligament reconstruction surgery. J Am Acad Orthop Surg. May-Jun 1999;7(3):189-98. [Medline].

  7. Hewson GF Jr, Mendini RA, Wang JB. Prophylactic knee bracing in college football. Am J Sports Med. Jul-Aug 1986;14(4):262-6. [Medline].

  8. Johnson DL, Harner CD, Maday MG. Revision anterior cruciate ligament surgery. Knee Surg. 1994;1:877-95.

  9. Kennedy JC, Alexander IJ, Hayes KC. Nerve supply of the human knee and its functional importance. Am J Sports Med. Nov-Dec 1982;10(6):329-35. [Medline].

  10. Larson RL, Tailon M. Anterior Cruciate Ligament Insufficiency: Principles of Treatment. J Am Acad Orthop Surg. Jan 1994;2(1):26-35. [Medline].

  11. Maday MG, Harner CD, Fu FH. Evaluation and Treatment. In: Feagin JA, ed. The Crucial Ligaments: Diagnosis, Treatment of Ligamentous Injuries About the Knee. 2nd. New York, NY: Churchill Livingstone; 1994:711-23.

  12. Miyasaka KC, Daniel DM, Stone ML. The incidence of knee ligament injuries in the general population. Am J of Knee Surg. 1991;4:3-8.

  13. Montgomery KD, Herschman EB, Nicholas S. Anterior cruciate ligament injuries. In: Arendt EA, ed. Orthopaedic Knowledge Update: Sports Medicine 2. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1999:307-316.

  14. Noyes FR, Bassett RW, Grood ES, Butler DL. Arthroscopy in acute traumatic hemarthrosis of the knee. Incidence of anterior cruciate tears and other injuries. J Bone Joint Surg Am. Jul 1980;62(5):687-95, 757. [Medline].

  15. Noyes FR, Butler DL, Grood ES, Zernicke RF, Hefzy MS. Biomechanical analysis of human ligament grafts used in knee-ligament repairs and reconstructions. J Bone Joint Surg Am. Mar 1984;66(3):344-52. [Medline].

  16. Shelbourne KD, Gray T. Anterior cruciate ligament reconstruction with autogenous patellar tendon graft followed by accelerated rehabilitation. A two- to nine-year followup. Am J Sports Med. Nov-Dec 1997;25(6):786-95. [Medline].

  17. Shelbourne KD, Nitz P. Accelerated rehabilitation after anterior cruciate ligament reconstruction. Am J Sports Med. May-Jun 1990;18(3):292-9. [Medline].

  18. Stanitski CL. Anterior Cruciate Ligament Injury in the Skeletally Immature Patient: Diagnosisand Treatment. J Am Acad Orthop Surg. May 1995;3(3):146-158. [Medline].

  19. Watson JT. Knee and leg: bone trauma. In: Beaty JH, ed. Orthopaedic Knowledge Update 6. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1999:521-32.

Further Reading

Keywords

ACL injury, knee injury, knee ligament injury, sprained knee, twisted knee, ACL injuries, anterior cruciate ligament injuries

Contributor Information and Disclosures

Author

John D Hubbell, MD, Consulting Surgeon, Department of Orthopedic Surgery, Southampton Hospital
John D Hubbell, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America, and Medical Society of the State of New York
Disclosure: Nothing to disclose.

Coauthor(s)

Evan Schwartz, MD, Director of Orthopedic Surgery, St John's Queens Hospital, New York Medical College; Assistant Professor, Department of Surgery, Albert Einstein School of Medicine
Evan Schwartz, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons and American Orthopaedic Society for Sports Medicine
Disclosure: Nothing to disclose.

Medical Editor

David T Bernhardt, MD, Director of Primary Care Sports Medicine Fellowship, Professor, Department of Pediatrics, University of Wisconsin
David T Bernhardt, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Sports Medicine, and American Medical Society for Sports Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Marlene DeMaio, MD, Consulting Staff, Assistant Professor, Department of Orthopedic Surgery, Bone & Joint/Sports Medicine Institute, Naval Medical Center
Marlene DeMaio, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Orthopaedic Surgeons, American College of Sports Medicine, American Orthopaedic Foot and Ankle Society, and American Orthopaedic Society for Sports Medicine
Disclosure: Nothing to disclose.

CME Editor

Jon Whitehurst, MD, Consulting Staff, Rockford Orthopedic Associates
Disclosure: Nothing to disclose.

Chief Editor

Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation, University of Chicago
Sherwin SW Ho, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.